Insight

Cancer Screening, Simplified: What to Consider and When to Start

Dominic Pennisi

Cancer screening can feel confusing because different tests start at different ages and recommendations may change as new evidence emerges.

The simplest way to approach screening is to remember what it’s designed for: detecting certain cancers early in people without symptoms, when treatment is often more effective.

Yale Medicine provides a clear overview of screening across multiple cancers and emphasizes that screening is most useful when matched to risk and the type of cancer. Yale Medicine

A key example: colorectal cancer screening now starts earlier for many people

The U.S. Preventive Services Task Force recommends colorectal cancer screening beginning at age 45 for average-risk adults, with strong support for screening through age 75 and selective screening later depending on health status. USPSTF+1

Harvard Health also notes that major organizations have moved toward starting screening at 45 for average-risk individuals, reflecting rising concern about earlier-onset trends. Harvard Health

Screening should be a shared decision—not a checklist

Not all screening decisions are identical for every person. The USPSTF has emphasized the importance of shared decision-making—helping patients weigh benefits and harms in context. USPSTF

Harvard Medical School has also highlighted how screening decisions (for example, in breast cancer screening) can benefit from tools that better personalize risk and support thoughtful decision-making. Harvard Medical School

A patient-friendly way to prepare for a screening conversation

Bring these 5 questions to your visit:

  1. What screenings are recommended for my age and sex?
  2. How does my family history change the plan?
  3. Do I have risk factors (smoking, exposures, prior findings) that shift timing?
  4. What are the potential downsides of this screening test?
  5. What happens if the test is abnormal—what’s the next step?

Bottom line

Screening isn’t about fear. It’s about timing and clarity. The best approach is evidence-based, personalized, and made with your clinician—especially as guidelines evolve. JAMA Network+1

Educational note: This is general education, not medical advice.